Skip to main content
SpringerLink
Log in

Abiraterone acetate

Various toxicities: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Caffo O, et al. Safety and clinical outcomes of abiraterone acetate (AA) after docetaxel (DOC) in octogenarians with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology 26 (Suppl. 6): vi61 abstr. F28, Oct 2015. Available from: URL: http://doi.org/10.1093/annonc/mdv341.28 [abstract] - Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abiraterone acetate. Reactions Weekly 1595, 14 (2016). https://doi.org/10.1007/s40278-016-16046-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-16046-3

Search

Navigation